Our findings revealed that silencing the NCAPH gene effectively suppressed proliferation, reduced cell cycle progression in prostate cancer cells by directly inhibiting the PI3K/AKT/mTOR pathway, and decreased the expression of the transcription factor E2F1. The gene discussed is NCAPH; the disease is prostate carcinoma.